SciSparc Finalizes Initial $2.0M Convertible Note Issuance at Significant Discount

summarizeSummary

SciSparc Ltd. finalized the issuance of an initial $2.0 million convertible promissory note for $1.8 million, representing a substantial and highly dilutive capital raise.

check_boxKey Events · Financing and Capital Events · SPRC

• Initial Convertible Note Finalized

  SciSparc Ltd. issued an initial convertible promissory note with a principal amount of $2.0 million to an institutional investor.

• Discounted Purchase Price

  The note was purchased for $1.8 million, reflecting a 10% discount to its principal value, representing a substantial portion of the company's market capitalization.

• Payment Contingent on Resale Registration

  The investor's obligation to pay the purchase price for the initial note is conditioned upon SciSparc filing a resale registration statement (Form F-3) covering the underlying shares and accompanying warrants.

• Consulting Agreement Offset Option

  The company may elect to offset amounts due under a consulting agreement with the investor against the purchase price payable for the initial or any additional notes.

auto_awesomeAnalysis · SPRC · Life Sciences

This 6-K provides definitive terms for the initial tranche of a previously announced convertible note financing, finalizing the issuance of a $2.0 million principal note for $1.8 million. This represents a substantial discount and is highly dilutive given the company's small market capitalization. The payment for this note is contingent on the filing of a resale registration statement, and the company may offset amounts due under a consulting agreement, indicating complex financing arrangements. This capital infusion is critical for the company's operations but comes at a high cost to existing shareholders, following a series of dilutive capital raises.